Galectin-2 (LGALS2) Active Protein

Name: LGALS2 Active Protein; Galectin-2; Research Grade; MyBioSource
Brand: MyBioSource
SKU: MBS846974
Price: 225 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS846974

Galectin 2; also known as Lgals2; belongs to the galectins family. Galectins are a family of soluble beta-galactoside-binding animal lectins that modulate cell-to-cell adhesion and cell-to-extracellular matrix (ECM) interactions and play a role in tumor… More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Product Name

Galectin-2 (Lgals2), Active Protein

Full Product Name

Galectin-2; mouse recombinant

Product Gene Name

Lgals2 active protein

Product Synonym Names

Lgals2; 2200008F12Rik; AI324147; Gal-2

Sequence

MGSSHHHHHH SSGLVPRGSH MGSMSEKFEV KDLNMKPGMS LKIKGKIHND VDRFLINLGQ GKETLNLHFN PRFDESTIVC NTSEGGRWGQ EQRENHMCFS PGSEVKITIT FQDKDFKVTL PDGHQLTFPN RLGHNQLHYL SMGGLQISSF KLE

Host

E Coli
Source: Mouse

Form/Format

Liquid
In 20 mM Tris-HCl buffer (pH 8.0) containing 0.1M NaCl; 10% glycerol; 1mM DTT

Purity/Purification

> 95%

Preparation and Storage

Store at -20 degree C for 12 months.
Centrifuge the vial prior to opening.

Molecular Weight

17.3 kDa

3D Structure

ModBase 3D Structure for Q9CQW5

Active Protein Note

Protein activity can be an ambiguous term. Please refer to the data sheet or inquire with Technical Support to determine the definition of activity for this product.

Activity

The ED50 for this effect is <=20 ug/ml. Measured by its ability to agglutinate human red blood cells.

Results

ED50 is <=20 ug/ml.

Applications Tested/Suitable for Lgals2 active protein

SDS-PAGE

Other Notes

Small volumes of Lgals2 active protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Lgals2 purchase

MBS846974 is an active protein targeting Lgals2. Also known as Galectin-2; mouse recombinant. Host: E Coli
Source: Mouse.

Additional Details

NCBI/Uniprot data below describe general gene information for Lgals2. It may not necessarily be applicable to this product.

NCBI GI #

13629138

NCBI GeneID

107753

NCBI Accession #

Q9CQW5.1

UniProt Primary Accession #

Q9CQW5

UniProt Secondary Accession #

Q9D800; Q9D862

UniProt Related Accession #

Q9CQW5

NCBI Official Full Name

Galectin-2

NCBI Official Synonym Full Names

lectin, galactose-binding, soluble 2

NCBI Official Symbol

Lgals2

NCBI Official Synonym Symbols

AI324147; 2200008F12Rik

UniProt Protein Name

Galectin-2

Protein Family

Galectin

UniProt Gene Name

Lgals2

UniProt Synonym Gene Names

Gal-2

NCBI Protein Information

galectin-2

UniProt Comments for Lgals2

galectin-2: This protein binds beta-galactoside. Its physiological function is not yet known.

Chromosomal Location of Human Ortholog: 15|15 E1

Molecular Function: galactoside binding

Research Articles on Lgals2

1. analysis of the effect of low-temperature plasma on the expression of galectin-1, -2, and -3 in the healing skin compared with those of electrocoagulation conducted with a high-frequency electrical coagulator

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Diseases associated with Lgals2 active protein

Disease Name	Pubmed Publications
Heart Diseases Antibodies	>24 publications with Lgals2 and Heart Diseases
Myocardial Infarction Antibodies	>24 publications with Lgals2 and Myocardial Infarction
Inflammation Antibodies	>19 publications with Lgals2 and Inflammation
Atherosclerosis Antibodies	>7 publications with Lgals2 and Atherosclerosis
Breast Neoplasms Antibodies	>3 publications with Lgals2 and Breast Neoplasms
Lung Neoplasms Antibodies	>3 publications with Lgals2 and Lung Neoplasms
Disease Models, Animal Antibodies	>3 publications with Lgals2 and Disease Models, Animal
Neoplasms, Experimental Antibodies	>2 publications with Lgals2 and Neoplasms, Experimental
Fibrosis Antibodies	>2 publications with Lgals2 and Fibrosis
Necrosis Antibodies	>2 publications with Lgals2 and Necrosis

Organs/Tissues associated with Lgals2 active protein

Organ/Tissue Name	Pubmed Publications
Intestine Antibodies	>11 publications with Lgals2 and Intestine
Stomach Antibodies	>6 publications with Lgals2 and Stomach
Embryonic Tissue Antibodies	>3 publications with Lgals2 and Embryonic Tissue
Uterus Antibodies	>2 publications with Lgals2 and Uterus
Pancreas Antibodies	>1 publications with Lgals2 and Pancreas